Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AMPE Ampio Pharmaceuticals Inc

-0.39 (-14.61%)
Dec 05 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 180,739
Bid Price
Ask Price
News -
Day High 2.73


52 Week Range


Day Low 2.28
Company Name Stock Ticker Symbol Market Type
Ampio Pharmaceuticals Inc AMPE AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.39 -14.61% 2.28 19:59:54
Open Price Low Price High Price Close Price Prev Close
2.36 2.28 2.73 2.28 2.67
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,232 180,739 $ 2.45 $ 443,393 - 1.86 - 8.298
Last Trade Time Type Quantity Stock Price Currency
20:00:00 400 $ 2.28 USD

Ampio Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
24.96k 832.02k - 0 -16.34M -19.64 0.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Ampio Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AMPE Message Board. Create One! See More Posts on AMPE Message Board See More Message Board Posts

Historical AMPE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.137.471.865.604,122,9270.157.04%
1 Month2.507.471.865.501,125,468-0.22-8.8%
3 Months5.007.471.865.41380,881-2.72-54.4%
6 Months5.808.2981.865.03426,328-3.52-60.69%
1 Year6.208.2981.865.05350,018-3.92-63.23%
3 Years318.00894.001.86262.762,439,700-315.72-99.28%
5 Years186.00894.001.86244.502,083,451-183.72-98.77%

Ampio Pharmaceuticals Description

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.

Your Recent History

Delayed Upgrade Clock